1 - 25 of 56 results for author:"Mitchell C.A." in Literature citations
Results Customize
› Repeat search in UniProtKB (30)
| Evidence for FHL1 as a novel disease gene for isolated hypertrophic cardiomyopathy. Friedrich F.W., Wilding B.R., Reischmann S., Crocini C., Lang P., Charron P., Muller O.J., McGrath M.J., Vollert I., Hansen A. et al. Hum. Mol. Genet. 21:3237-3254(2012) · Mapped (23) |
| Structure of PA1221, a nonribosomal peptide synthetase containing adenylation and peptidyl carrier protein domains. Mitchell C.A., Shi C., Aldrich C.C., Gulick A.M. Biochemistry 51:3252-3263(2012) · UniProtKB (1) |
| Hypertrophy and dietary tyrosine ameliorate the phenotypes of a mouse model of severe nemaline myopathy. Nguyen M.A., Joya J.E., Kee A.J., Domazetovska A., Yang N., Hook J.W., Lemckert F.A., Kettle E., Valova V.A., Robinson P.J. et al. Brain 134:3516-3529(2011) · Mapped (3) |
| Identification of P-Rex1 as a novel Rac1-guanine nucleotide exchange factor (GEF) that promotes actin remodeling and GLUT4 protein trafficking in adipocytes. Balamatsias D., Kong A.M., Waters J.E., Sriratana A., Gurung R., Bailey C.G., Rasko J.E., Tiganis T., Macaulay S.L., Mitchell C.A. J. Biol. Chem. 286:43229-43240(2011) · Mapped (6) |
| Silencer of death domains (SODD) inhibits skeletal muscle and kidney enriched inositol 5-phosphatase (SKIP) and regulates phosphoinositide 3-kinase (PI3K)/Akt signaling to the actin cytoskeleton. Rahman P., Huysmans R.D., Wiradjaja F., Gurung R., Ooms L.M., Sheffield D.A., Dyson J.M., Layton M.J., Sriratana A., Takada H. et al. J. Biol. Chem. 286:29758-29770(2011) · Mapped (11) |
| Identification of a proline-rich inositol polyphosphate 5-phosphatase (PIPP)•collapsin response mediator protein 2 (CRMP2) complex that regulates neurite elongation. Astle M.V., Ooms L.M., Cole A.R., Binge L.C., Dyson J.M., Layton M.J., Petratos S., Sutherland C., Mitchell C.A. J. Biol. Chem. 286:23407-23418(2011) · Mapped (1) |
| A mutation in synaptojanin 2 causes progressive hearing loss in the ENU-mutagenised mouse strain Mozart. Manji S.S., Williams L.H., Miller K.A., Ooms L.M., Bahlo M., Mitchell C.A., Dahl H.H. PLoS ONE 6:e17607-e17607(2011) · Mapped (25) |
| An ENU-induced mouse mutant of SHIP1 reveals a critical role of the stem cell isoform for suppression of macrophage activation. Nguyen N.Y., Maxwell M.J., Ooms L.M., Davies E.M., Hilton A.A., Collinge J.E., Hilton D.J., Kile B.T., Mitchell C.A., Hibbs M.L. et al. Blood 117:5362-5371(2011) · Mapped (7) |
| Four and a half LIM protein 1 gene mutations cause four distinct human myopathies: a comprehensive review of the clinical, histological and pathological features. Cowling B.S., Cottle D.L., Wilding B.R., D'Arcy C.E., Mitchell C.A., McGrath M.J. Neuromuscul. Disord. 21:237-251(2011) · Mapped (15) |
| Inositol polyphosphate 4-phosphatase II regulates PI3K/Akt signaling and is lost in human basal-like breast cancers. Fedele C.G., Ooms L.M., Ho M., Vieusseux J., O'Toole S.A., Millar E.K., Lopez-Knowles E., Sriratana A., Gurung R., Baglietto L. et al. Proc. Natl. Acad. Sci. U.S.A. 107:22231-22236(2010) · Mapped (11) |
| The myotubularin phosphatase MTMR4 regulates sorting from early endosomes. Naughtin M.J., Sheffield D.A., Rahman P., Hughes W.E., Gurung R., Stow J.L., Nandurkar H.H., Dyson J.M., Mitchell C.A. J. Cell. Sci. 123:3071-3083(2010) · Mapped (1) |
| Reactive oxygen species enhance insulin sensitivity. Loh K., Deng H., Fukushima A., Cai X., Boivin B., Galic S., Bruce C., Shields B.J., Skiba B., Ooms L.M. et al. Cell Metab. 10:260-272(2009) · Mapped (2) |
| SLIMMER (FHL1B/KyoT3) interacts with the proapoptotic protein Siva-1 (CD27BP) and delays skeletal myoblast apoptosis. Cottle D.L., McGrath M.J., Wilding B.R., Cowling B.S., Kane J.M., D'Arcy C.E., Holdsworth M., Hatzinisiriou I., Prescott M., Brown S. et al. J. Biol. Chem. 284:26964-26977(2009) · Mapped (10) |
| Regulation of PI(3)K/Akt signalling and cellular transformation by inositol polyphosphate 4-phosphatase-1. Ivetac I., Gurung R., Hakim S., Horan K.A., Sheffield D.A., Binge L.C., Majerus P.W., Tiganis T., Mitchell C.A. EMBO Rep. 10:487-493(2009) · Mapped (11) |
| Clinical, histological and genetic characterization of reducing body myopathy caused by mutations in FHL1. Schessl J., Taratuto A.L., Sewry C., Battini R., Chin S.S., Maiti B., Dubrovsky A.L., Erro M.G., Espada G., Robertella M. et al. Brain 132:452-464(2009) · Mapped (15) |
| Identification of FHL1 as a regulator of skeletal muscle mass: implications for human myopathy. Cowling B.S., McGrath M.J., Nguyen M.A., Cottle D.L., Kee A.J., Brown S., Schessl J., Zou Y., Joya J., Bonnemann C.G. et al. J. Cell Biol. 183:1033-1048(2008) · Mapped (18) |
| P-Rex1 - a multidomain protein that regulates neurite differentiation. Waters J.E., Astle M.V., Ooms L.M., Balamatsias D., Gurung R., Mitchell C.A. J. Cell. Sci. 121:2892-2903(2008) · Mapped (3) |
| Antihemostatic activity of human granzyme B mediated by cleavage of von Willebrand factor. Buzza M.S., Dyson J.M., Choi H., Gardiner E.E., Andrews R.K., Kaiserman D., Mitchell C.A., Berndt M.C., Dong J.F., Bird P.I. J. Biol. Chem. 283:22498-22504(2008) · Mapped (6) |
| Four and a half LIM protein 1: a partner for KCNA5 in human atrium. Yang Z., Browning C.F., Hallaq H., Yermalitskaya L., Esker J., Hall M.R., Link A.J., Ham A.J., McGrath M.J., Mitchell C.A. et al. Cardiovasc. Res. 78:449-457(2008) · Mapped (16) |
| Proteomic identification of FHL1 as the protein mutated in human reducing body myopathy. Schessl J., Zou Y., McGrath M.J., Cowling B.S., Maiti B., Chin S.S., Sewry C., Battini R., Hu Y., Cottle D.L. et al. J. Clin. Invest. 118:904-912(2008) · UniProtKB (1) · Mapped (14) |
| Regulation of FcgammaR-stimulated phagocytosis by the 72-kDa inositol polyphosphate 5-phosphatase: SHIP1, but not the 72-kDa 5-phosphatase, regulates complement receptor 3 mediated phagocytosis by differential recruitment of these 5-phosphatases to the phagocytic cup. Horan K.A., Watanabe K., Kong A.M., Bailey C.G., Rasko J.E., Sasaki T., Mitchell C.A. Blood 110:4480-4491(2007) · Mapped (18) |
| The Shc-binding site of the betac subunit of the GM-CSF/IL-3/IL-5 receptors is a negative regulator of hematopoiesis. Ramshaw H.S., Guthridge M.A., Stomski F.C., Barry E.F., Ooms L., Mitchell C.A., Begley C.G., Lopez A.F. Blood 110:3582-3590(2007) · Mapped (11) |
| Inactivation of the phosphoinositide phosphatases Sac1p and Inp54p leads to accumulation of phosphatidylinositol 4,5-bisphosphate on vacuole membranes and vacuolar fusion defects. Wiradjaja F., Ooms L.M., Tahirovic S., Kuhne E., Devenish R.J., Munn A.L., Piper R.C., Mayinger P., Mitchell C.A. J. Biol. Chem. 282:16295-16307(2007) · Mapped (2) |
| FHL3 binds MyoD and negatively regulates myotube formation. Cottle D.L., McGrath M.J., Cowling B.S., Coghill I.D., Brown S., Mitchell C.A. J. Cell. Sci. 120:1423-1435(2007) · Mapped (6) |
| Microphthalmia, persistent hyperplastic hyaloid vasculature and lens anomalies following overexpression of VEGF-A188 from the alphaA-crystallin promoter. Rutland C.S., Mitchell C.A., Nasir M., Konerding M.A., Drexler H.C. Mol. Vis. 13:47-56(2007) · Mapped (23) |